CliffBio
small molecule

INDOMETHACIN

INDOMETHACIN

Loss of exclusivity—loss of exclusivity
CompanyCosette Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameINDOMETHACIN
Active ingredientINDOMETHACIN
Strength50MG
Dosage formSUPPOSITORY
RouteRECTAL
ModalitySmall molecule
FDA approvalAugust 1992
Marketing statusRX

More from Cosette Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.